Abstract
Adopting a place-based approach to categorization, we explore how and why institutional actors in the US and the UK have categorized e-cigarettes differently, namely as tobacco products in the US and as non-tobacco consumer products in the UK. Our inquiry identified the historical contingencies generating two different perspectives informing these differential categorizations—precautionary in the US and harm-reduction in the UK. Embedded in these two perspectives are different future imaginaries to address the harm from cigarettes and e-cigarettes to the different population groups at risk (i.e. smokers versus youth and non-smokers). Data also show institutional actors across the two countries offering justifications for or against e-cigarettes by deploying facts from different scientific research. We theorize these findings and conclude the article by discussing the importance of adopting a place-based approach to categorization.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
